Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring（2015）
摘要
Plasma DES/CHO is decreased in AD patients and may serve as a longitudinal surrogate marker associated with cognitive decline.
更多查看译文
关键词
Alzheimer's disease,Mild cognitive impairment,Blood-based biomarker,Desmosterol,Longitudinal biomarker
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要